Therapeutic applications of nuclear medicine are expanding. Until 5–10 years ago, the use
of radioisotopes in therapy was limited predominantly to treatment of hyperthyroidism …

Radiopharmaceuticals have been developed to image selectively most of the organ systems
of the body. Most commonly, these agents are labelled with the gamma-emitters technetium …

The concept of theragnostics goes back to the earliest days of nuclear medicine, with
[123i/131i] iodide in thyroid disease and [123i/131i] MiBg in phaeochromocytoma being …

Further individualization of thyroid cancer patient care by means of I-124-positron emission
tomography and computed X-ray tomography-based selection of the therapeutic strategy is …

Terbium-161 is a b-emitting radionuclide that resembles 177Lu in terms of its in vivo and in
vitro chemical and pharmacokinetic properties, exhibiting similar behavior with regard to …

The term last mile originates from the telecommunication industry and describes the difficulty
of connecting the end customer to the main telecommunication networks (1). Successfully …

Simple Summary This review summarizes recent advances in the nuclear medicine
theranostic approach. It covers the repurposing of historical radiotracers for new indications …

The purpose of the EANM Dosimetry Committee is to provide recommendations and
guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals …

The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …

Radiopharmaceutical therapy is an emerging treatment modality that has demonstrated
increasing importance as a significant component in the treatment of cancer. Prostate cancer …